Predicting ICU admission in community-acquired pneumonia

Clinical scores and biomarkers

Juan F. Fernandez, Oriol Sibila, Marcos Restrepo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Community-acquired pneumonia (CAP) remains a common and serious worldwide health problem. Despite all the advances in therapy, significant interest has focused on the identification of patients with CAP who require intensive care unit admission to improve their outcomes. The severity assessment of CAP provides an important guide to clinicians in deciding the site of care and the use of empiric antibiotics and adjuvant therapy. For years, several clinical assessment scores have been suggested and validated to achieve this goal. The recent introduction of biomarkers as prognostic indicators of severe CAP, whether used alone or in conjunction with other clinical severity of illness scores, has been investigated. An objective scoring system with a high level of sensitivity and specificity to predict the severity of CAP and the need for high levels of care do not exist. Today, the addition of clinical scores and biomarkers to clinical judgment is the best approach to optimize the care of severe CAP. Future research will allow validation of these and newer tools to improve the prognosis of patients with CAP.

Original languageEnglish (US)
Pages (from-to)445-458
Number of pages14
JournalExpert Review of Clinical Pharmacology
Volume5
Issue number4
DOIs
StatePublished - Jul 2012

Fingerprint

Pneumonia
Biomarkers
Intensive Care Units
Anti-Bacterial Agents
Sensitivity and Specificity
Therapeutics

Keywords

  • biomarkers
  • community-acquired infections
  • ICU
  • pneumonia
  • score
  • severity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Predicting ICU admission in community-acquired pneumonia : Clinical scores and biomarkers. / Fernandez, Juan F.; Sibila, Oriol; Restrepo, Marcos.

In: Expert Review of Clinical Pharmacology, Vol. 5, No. 4, 07.2012, p. 445-458.

Research output: Contribution to journalArticle

@article{916c0f8f52e34cc2a277f9b0748a5547,
title = "Predicting ICU admission in community-acquired pneumonia: Clinical scores and biomarkers",
abstract = "Community-acquired pneumonia (CAP) remains a common and serious worldwide health problem. Despite all the advances in therapy, significant interest has focused on the identification of patients with CAP who require intensive care unit admission to improve their outcomes. The severity assessment of CAP provides an important guide to clinicians in deciding the site of care and the use of empiric antibiotics and adjuvant therapy. For years, several clinical assessment scores have been suggested and validated to achieve this goal. The recent introduction of biomarkers as prognostic indicators of severe CAP, whether used alone or in conjunction with other clinical severity of illness scores, has been investigated. An objective scoring system with a high level of sensitivity and specificity to predict the severity of CAP and the need for high levels of care do not exist. Today, the addition of clinical scores and biomarkers to clinical judgment is the best approach to optimize the care of severe CAP. Future research will allow validation of these and newer tools to improve the prognosis of patients with CAP.",
keywords = "biomarkers, community-acquired infections, ICU, pneumonia, score, severity",
author = "Fernandez, {Juan F.} and Oriol Sibila and Marcos Restrepo",
year = "2012",
month = "7",
doi = "10.1586/ecp.12.28",
language = "English (US)",
volume = "5",
pages = "445--458",
journal = "Expert Review of Clinical Pharmacology",
issn = "1751-2433",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Predicting ICU admission in community-acquired pneumonia

T2 - Clinical scores and biomarkers

AU - Fernandez, Juan F.

AU - Sibila, Oriol

AU - Restrepo, Marcos

PY - 2012/7

Y1 - 2012/7

N2 - Community-acquired pneumonia (CAP) remains a common and serious worldwide health problem. Despite all the advances in therapy, significant interest has focused on the identification of patients with CAP who require intensive care unit admission to improve their outcomes. The severity assessment of CAP provides an important guide to clinicians in deciding the site of care and the use of empiric antibiotics and adjuvant therapy. For years, several clinical assessment scores have been suggested and validated to achieve this goal. The recent introduction of biomarkers as prognostic indicators of severe CAP, whether used alone or in conjunction with other clinical severity of illness scores, has been investigated. An objective scoring system with a high level of sensitivity and specificity to predict the severity of CAP and the need for high levels of care do not exist. Today, the addition of clinical scores and biomarkers to clinical judgment is the best approach to optimize the care of severe CAP. Future research will allow validation of these and newer tools to improve the prognosis of patients with CAP.

AB - Community-acquired pneumonia (CAP) remains a common and serious worldwide health problem. Despite all the advances in therapy, significant interest has focused on the identification of patients with CAP who require intensive care unit admission to improve their outcomes. The severity assessment of CAP provides an important guide to clinicians in deciding the site of care and the use of empiric antibiotics and adjuvant therapy. For years, several clinical assessment scores have been suggested and validated to achieve this goal. The recent introduction of biomarkers as prognostic indicators of severe CAP, whether used alone or in conjunction with other clinical severity of illness scores, has been investigated. An objective scoring system with a high level of sensitivity and specificity to predict the severity of CAP and the need for high levels of care do not exist. Today, the addition of clinical scores and biomarkers to clinical judgment is the best approach to optimize the care of severe CAP. Future research will allow validation of these and newer tools to improve the prognosis of patients with CAP.

KW - biomarkers

KW - community-acquired infections

KW - ICU

KW - pneumonia

KW - score

KW - severity

UR - http://www.scopus.com/inward/record.url?scp=84866120214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866120214&partnerID=8YFLogxK

U2 - 10.1586/ecp.12.28

DO - 10.1586/ecp.12.28

M3 - Article

VL - 5

SP - 445

EP - 458

JO - Expert Review of Clinical Pharmacology

JF - Expert Review of Clinical Pharmacology

SN - 1751-2433

IS - 4

ER -